• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004 Sep 15; 173(6):4171-8.

View in: PubMed

subject areas
  • Adjuvants, Immunologic
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal
  • Autoantibodies
  • CD3 Complex
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Cells, Cultured
  • Disease Progression
  • Female
  • Glomerular Mesangium
  • Histocompatibility Antigens Class II
  • Histone Deacetylase Inhibitors
  • Hydroxamic Acids
  • Immunosuppressive Agents
  • Inflammation Mediators
  • Injections, Intraperitoneal
  • Lupus Erythematosus, Systemic
  • Lymphopenia
  • Mice
  • Mice, Inbred MRL lpr
  • Organ Size
  • Proteinuria
  • Spleen

authors with profiles
  • Gary S. Gilkeson